2
Participants
Start Date
February 28, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
Peginterferon alfa-2b (Pegetron) plus ribavirin (Rebetol)
Dosage Form: Pegetron - powder for solution; Rebetol - capsules Strength: Pegetron Redipen - 120 mcg per pen; Rebetol - 200 mg Route of Administration: Pegetron - subcutaneous; Rebetol - oral
Calgary Heart Centre, Calgary
Hys Med Centre, Edmonton
Liver and Intestinal Research Centre, Vancouver
Dr. John D Farley Medical Office, Vancouver
Pacific Gastroenterology Assoc, Vancouver
Hotel Dieu Hospital, Kingston
London Health Sciences Centre, London
Dr. Dalia El-Ashry clinic, Mississauga
Credit Valley Med Arts Centre, Mississauga
Toronto General Hospital - Dr. M. Sherman, Toronto
Toronto Western Hospital - Liver Clinic, Toronto
SMBD Jewish Gen Hosp, Montreal
Collaborators (1)
Schering-Plough
INDUSTRY
University Health Network, Toronto
OTHER